SUPN
Supernus Pharmaceuticals Inc.
$46.98
+$0.94(+2.04%)
82
Overall
75
Value
90
Tech
--
Quality
Market Cap
$2.58B
Volume
681.85K
52W Range
$29.16 - $46.79
Target Price
$43.80
Key Metrics Overview
| Market Cap | $2.58B | P/E Ratio | 29.00 |
| 52W High | $46.79 | 52W Low | $29.16 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 9.9% | 52W Position | 101.1% |
| Overall Score | 82 | Value Score | 75 |
| Quality Score | -- | Technical Score | 90 |
Growth Analysis
| EPS Current Est | $1.62 | EPS Next Est | $1.75 |
| EPS Growth Est | +8.0% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SUPN | $46.98 | +2.0% | 681.85K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Supernus Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW